Works by Kanda, Hideki


Results: 88
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 663, doi. 10.1007/s00262-020-02483-1
    By:
    • Ishihara, Mikiya;
    • Tono, Yasutaka;
    • Miyahara, Yoshihiro;
    • Muraoka, Daisuke;
    • Harada, Naozumi;
    • Kageyama, Shinichi;
    • Sasaki, Takeshi;
    • Hori, Yasuhide;
    • Soga, Norihito;
    • Uchida, Katsunori;
    • Shiraishi, Taizo;
    • Sato, Eiichi;
    • Kanda, Hideki;
    • Mizuno, Toshiro;
    • Webster, Gill A.;
    • Ikeda, Hiroaki;
    • Katayama, Naoyuki;
    • Sugimura, Yoshiki;
    • Shiku, Hiroshi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study.

    Published in:
    Japanese Journal of Clinical Oncology, 2016, v. 46, n. 12, p. 1156, doi. 10.1093/jjco/hyw130
    By:
    • Kei Mizuno;
    • Takahiro Inoue;
    • Hidefumi Kinoshita;
    • Toshifumi Yano;
    • Hiroaki Kawanishi;
    • Hideki Kanda;
    • Naoki Terada;
    • Takashi Kobayashi;
    • Tomomi Kamba;
    • Yoshiki Mikami;
    • Taizo Shiraishi;
    • Yoshiko Uemura;
    • Yukihiro Imai;
    • Gen Honjo;
    • Tomoyuki Shirase;
    • Kazuhiro Okumura;
    • Mutsushi Kawakita;
    • Keiji Ogura;
    • Yoshiki Sugimura;
    • Tadashi Matsuda
    Publication type:
    Article